Profound Medical (PROF) Reports Q1 Loss, Misses Revenue Estimates

分组1 - Profound Medical reported a quarterly loss of $0.36 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.29, and a decline from a loss of $0.26 per share a year ago, indicating an earnings surprise of -24.14% [1] - The company generated revenues of $2.62 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 24.03%, and showing an increase from $1.91 million in the same quarter last year [2] - Profound Medical shares have decreased by approximately 36% since the beginning of the year, contrasting with the S&P 500's decline of -4.3% [3] 分组2 - The earnings outlook for Profound Medical is mixed, with the current consensus EPS estimate for the upcoming quarter at -$0.27 on revenues of $4.2 million, and for the current fiscal year at -$1.06 on revenues of $19.04 million [7] - The Medical - Drugs industry, to which Profound Medical belongs, is currently ranked in the top 26% of over 250 Zacks industries, suggesting a favorable industry outlook [8]